Method validation is a critical activity in biopharmaceutical product development which
often causes confusion and, at times, consternation on the part of analytical development
teams. Questions surrounding method validation abound: (1) when should we validate our
analytical methods? (2) what are the requirements for achieving method validation in a
manner that is compliant across multiple regulatory jurisdictions around the world? (3) how
can I implement a validation strategy that fits my company’s business infrastructure and
provides for seamless method transfer activities to other QC organizations in the company
as well as contract QC organizations, when required?